▼ -11.27% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Bruker in the last 3 months. The average price target is $44.95, with a high forecast of $63.00 and a low forecast of $27.00. The average price target represents a -11.27% upside from the last price of $50.66.
The current consensus among 9 polled investment analysts is to hold stock in Bruker. This rating has held steady since May 2020, when it changed from a Buy consensus rating.
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.